Transplant Infectious Disease

Article	Citations
	89
	55
Pediatric solid organ transplant recipients positive for severe acute respiratory syndrome coronavirus 2 pre‐transplant	39
Histoplasma capsulatum tenosynovitis: An unusual presentation in a kidney transplant recipient	39
Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?	35
1,3‐β‐D‐glucan testing for nocardiosis in solid organ transplant recipients	32
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review	32
Successful treatment of Rhodococcus lung abscess and empyema thoracis in a heart transplant recipient	30
SARS‐CoV‐2 seropositivity in renal transplant patients administered intravenous immunoglobulin	29
Comparative 3‐Year Allograft Outcomes for Recipients of Kidneys From SARS‐CoV‐2 NAT‐Positive Donors	27
Nitazoxanide for Enterocytozoon bieneusi intestinal microsporidiosis	26
Impact of Donor Radiographic Pneumonia on Posttransplant Recipient Outcomes and Microbiology	26
Healthcare resource utilization of maribavir versus investigator‐assigned therapy in transplant recipients with cytomegalovirus infection refractory (with or without genotypic resistance) to prior tre	26
Outcome of Liver Transplantation for Critically Ill Acute on Chronic Liver Failure Recipients Complicated With Pretransplant Invasive Pulmonary Aspergillosis	26
A Comparison of a Solid Organ Transplant Population‐Specific Antibiogram With the Hospital‐Wide Antibiogram	25
Disseminated Acanthamoeba Infection After Heart‐Lung Transplantation	25
Hospital‐Acquired Respiratory Viral Infections (HA‐RVIs) Over 10 Years Disproportionally Affect the Immunocompromised	25
Perspectives on biovigilance and transmission of infection of donor origin in deceased organ donation—The evolving scenario in the United Kingdom	24
Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient	23
Point‐of‐Care Testing by Multiplex‐PCR in Different Compartments in Suspected Lower Respiratory Tract Infection After Lung Transplantation—Results of a Prospective Study	21
Immunocompromised Host Infectious Diseases: A Recommended Educational Content Outline for Advanced Practice Providers	21
Utility of microbiologic testing in surveillance bronchoscopy following lung transplantation: A retrospective cohort study	19
Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation – Single‐center experience and review	18
Pathogen‐agnostic immune biomarkers that predict infection after solid organ transplantation	18
Outcome of Pneumocystis pneumonia in transplant and non‐transplant HIV‐negative immunocompromised patients	18

Clinical Utility of Bronchoalveolar Lavage PCR for Nocardia and Mucorales in Lung Transplant Recipients: A Retrospective Cohort Study	18
Incidence, Risk Factors, and Clinical Outcomes of Active Tuberculosis in Kidney Transplant Recipients From Romania: A Single‐Center Study	17
Atypical pneumonia testing in transplant recipients	17
Cover Image	17
Research Advice for Early Career Transplant Infectious Disease Clinicians	17
Neuroinvasive West Nile virus infection in solid organ transplant recipients	17
Prognostic Impact of Cytomegalovirus Reactivation After Transplantation From Cord Blood Compared to Other Donor Sources in Patients With Adult T‐Cell Leukemia/Lymphoma in the Pre‐Letermovir Era	17
Evaluation of Titer‐Proven Response Rates of Pediatric Hepatitis B‐Combination Vaccines in Adult Hematopoietic Cell Transplant Recipients	16
Ultrasound for management of left ventricular assist device driveline infections: A single‐center experience	16
Cytomegalovirus‐Induced Arterial Intimal Fibrosis in the Kidney Transplant	16
The Journal in 2024: Reflections and Thanks for Our Reviewers	16
Perspectives on donor‐derived infections from the Notify Library	15
Importance of antimicrobial stewardship in solid organ transplant recipients: An ESCMID perspective	15
Immediate Donor‐Derived Hepatitis C Transmission Following Kidney Transplantation: A Two‐Case Observation	15
Could cell‐free DNA and host biomarkers assist in antimicrobial stewardship with organ transplant recipients?	14
Metagenomics in infectious disease diagnostics: Toward best‐use practices to optimize actionable results	14
Trends over Time in Practice and Outcomes of Lung Transplantation in Recipients With Human Immunodeficiency Virus	14
Role of cytomegalovirus specific cell‐mediated immunity in the monitoring of cytomegalovirus infection among living donor liver transplantation adult recipients: A single‐center experience	13
Evaluation of oral herpes simplex virus shedding among solid organ transplant recipients: A pilot study	13
ChatGPT may help in counseling on strategies for safe living following solid organ transplantation	13
Impact of coronavirus disease 2019 monoclonal antibodies on outcomes of coronavirus disease 2019 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients	13
Emergent Total Gastrectomy for Gas Gangrene of the Stomach due to Clostridium butyricum After Living Donor Liver Transplantation	13
Antifungal stewardship in solid‐organ transplantation: What is needed?	13
Surveillance for donor‐derived infections in Australia	12
Impact of CD19 CAR T‐Cell Therapy on Pathogen‐Specific Antibody Titers in Lymphoma Patients	12
A Matched Case‐Control Study to Evaluate Predicted Drug Exposures and Neutropenia during Valganciclovir Prophylaxis in Pediatric Solid Organ Transplant Recipients	12
Real‐World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients	12
Impact of machine perfusion on transplant infectious diseases: New challenges and opportunities	12
The Swiss Transplant Cohort Study: Implications for Transplant Infectious Diseases Research	12
Invalid Nucleic Acid Test Results May Limit Deceased Donor Organ Utilization	12
A Powerful Predictor Is Not yet an Actionable One: Contextualizing the Posttransplant VRE Colonization Score	11
EBV‐Related Posttransplant Lymphoproliferative Disorder After Transplantation of EBV‐Infected Peripheral Blood Stem Cell Collection With Posttransplant Cyclophosphamide as GVHD Prophylaxis	11
The American Association of Tissue Banks tissue donor screening for Mycobacterium tuberculosis—Recommended criteria and literature review	11
The Changing Epidemiology of Breakthrough Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Era of Modified‐Release Posaconazole Prophylaxis	11
Real‐world experience in treatment of donor‐derived Hepatitis C virus in kidney transplant recipients with delayed initiation, shortened course glecaprevir/pibrentasvir versus standard of care	11
Microbial Contamination in Deceased Musculoskeletal Tissue Donors: A Large‐Scale US Analysis of Infection Risk	11
Predicting VRE Infection After Liver Transplantation With a Time‐Updated Colonization Score	11
Outcomes of Invasive Aspergillosis in Liver Transplant Recipients From an Institution Using Targeted Antifungal Prophylaxis and an Antifungal Stewardship Program	11
Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug‐resistant Burkholderia multivorans	11
Real‐world experience of tixagevimab‐cilgavimab pre‐exposure prophylaxis in orthotopic heart transplant recipients	10
Impact of an ultrasensitive Cytomegalovirus quantitative nucleic acid test on Cytomegalovirus detection and therapy in renal transplant recipients	10
Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin	10
Not Just an Oxymoron: The Utilitarian's Guide to Antimicrobial Stewardship in Transplant Infectious Diseases	10
Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Di	10
Clinical Analysis of Tuberculosis in Children and Adolescents Treated for Malignancy or Undergoing Hematopoietic Cell Transplantation—A Multicenter Nationwide Study	10
Shorter is better: The case for short antibiotic courses for common infections in solid organ transplant recipients	10
Outcomes in solid organ transplant recipients receiving organs from a donor with Fusarium solani species complex meningitis	10
Donor‐derived infections: The Swiss perspective	10
Disseminated histoplasmosis with refractory thrombocytopenia in a renal transplant patient	9
Systematic fungal biomarker or polymerase chain reaction testing in lung transplant recipients: Retrospective analysis to optimize their use	9

The ID Digital Institute: Building a digital education toolset and community	9
Incidence of breakthrough fungal infections on isavuconazole prophylaxis compared to posaconazole and voriconazole	9
Paradoxical outcomes of gram‐negative bloodstream infection in solid organ transplant recipients	9
Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches	9
Cytomegalovirus‐driven early‐onset lymphocytosis in hematopoietic allogeneic transplant mimicking a T‐cell lymphoma progression	9
Correction to “Treatment of asymptomatic bacteriuria in the first 2 months after kidney transplant: A controlled clinical trial”	9
When you need to dive in the deep end—Transplanting SARS‐CoV‐2 PCR+ recipients	9
Fluoroquinolone prophylaxis in patients with neutropenia at high risk of serious infections: Exploring pros and cons	9
Previous use of statins does not improve the outcome of bloodstream infection after kidney transplantation	9
A rapid point‐of‐care polymerase chain reaction test in suspected viral respiratory tract infection after lung transplantation – A single‐center experience	9
Twice Weekly Sulfamethoxazole/Trimethoprim for Pneumocystis jiroveci Pneumonia Prophylaxis in Lung Transplant Recipients	9
Surgical site infection due to Mycobacterium fortuitum in a lung transplant recipient	9
Cytomegalovirus reactivation and recalcitrant oral ulcers following coronavirus disease 2019 infection in a kidney transplant recipient	9
Preferences in treating polyomavirus infection in kidney transplant recipients: A discrete choice experiment with patients, caregivers, and clinicians	9
Riders on the Storm	9
Revised nucleic acid test window periods: Applications and limitations in organ donation practice	9
Aspergillus spp. renal arteritis after kidney transplantation: A reappraisal	9
QuantiFERON monitor predicts early cytomegalovirus infection and viral burden in allogeneic hematopoietic stem cell transplantation	9
Treatment of asymptomatic bacteriuria in the first 2 months after kidney transplant: A controlled clinical trial	9
Characteristics and Clinical Outcomes of Postoperative Pleural Space Infections Among Lung Transplant Recipients	9
Novel intervention based on an individualized bundle of care to decrease infection in kidney transplant recipients	9
Seroconversion after COVID‐19 vaccination and heart transplant recipients: Correspondence	9
Difference in immunosuppressant dose requirement when transitioning to isavuconazole from other azoles in thoracic transplant recipients	9
Pre‐engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis	8
Incidence and Timing of Epstein–Barr Virus Whole Blood DNAemia in Epstein–Barr Virus‐Mismatched Adult and Pediatric Solid Organ Transplant Recipients	8
Impact of Bebtelovimab Treatment Timing on COVID‐19 Outcomes in Ambulatory Solid Organ Transplant Recipients	8
When a fungal infection is worse than a leukemia diagnosis	8
Donor‐derived infections: Current practice, global strategies, and future challenges	8
Disseminated histoplasmosis with central nervous system involvement in a kidney transplant recipient	8
Minocycline‐induced hyperpigmentation in a patient on long‐term Nocardia suppressive treatment	8
	8
CMV‐Associated Worsening of Neurological Symptoms in Kearns–Sayre Syndrome After Heart Transplantation: A Case Report	8
Longitudinal impact of COVID‐19 on lung function in lung transplant recipients: Time to stop worrying?	8
Disseminated Mycobacterium abscessus secondary to adult onset immunodeficiency syndrome due to anti‐interferon gamma autoantibodies	8
Breakthrough SARS‐CoV‐2 infections among recipients of tixagevimab‐cilgavimab prophylaxis: A citywide real‐world effectiveness study	7
Issue Information	7
Screening and Reactivation of Chagas Disease Among Solid Organ Transplant Candidates and Recipients: A 10‐Year Single Center Experience in Florida	7
Systemic corticosteroids for outpatient respiratory viral infections in lung transplant recipients	7
Prevention and management of infectious and tropical diseases in kidney transplant recipients residing in European outermost and overseas territories	7
Duration of antibiotics in kidney transplant recipients with pyelonephritis: Current practice, research gaps, and future research	7
Mortality Associated With Cytomegalovirus Reactivation After Umbilical Cord Blood HCT	7
Incidental Detection of Respiratory Viruses in Lung Transplant Donor‐Recipient Pairs: Exploratory Associations With Clinical Outcomes in a Post Hoc Analysis	7
Bridging the Gaps in CMV Management in Transplantation: Lessons From Resource‐Limited Settings	7
Nontuberculous mycobacterial infections in patients with hematologic malignancies and recipients of hematopoietic stem cell transplantation	7
Antibiotic Tolerability in Nocardia Infection Among Kidney Transplant Recipients: A Multicenter Cohort Study	7
Poor hospitalization outcomes in patients undergoing allogeneic hematopoietic stem cell transplant with hospital acquired influenza infection	7
Donor‐derived fulminant herpes simplex virus hepatitis after liver transplantation: Two cases and review of literature	7
Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis?	7
Safety and Efficacy of MV140 Sublingual Vaccine (Uromune) in Preventing Recurrent Urine Infections Post Renal Transplant: A Case Series	7
The intricate interplay of immunosuppression and outcomes following Gram‐negative bloodstream infection in solid organ transplantation	7
Cytomegalovirus related hospitalization costs among hematopoietic stem cell and solid organ transplant recipients treated with maribavir versus investigator‐assigned therapy: A US‐based study	7
Antibacterial prophylaxis for neutropenic and high‐risk hematology patients—Do the benefits outweigh the risk?	7
Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia With Active Left Neck Tuberculosis: A Case Report	6
Hepatic granulomas in a pediatric liver transplant recipient	6
Use of the QuantiFERON Monitor Assay to Predict Clinical Outcomes in Solid Organ and Hematopoietic Cell Transplant Recipients: A Scoping Review	6
Making Sense of Mollicute Screening in Lung Transplant Recipients: Challenges and Opportunities	6
Impact of Doxycycline Prophylaxis on Reducing Ureaplasma and Mycoplasma ‐Related Complications in Lung Tra	6
Transplant of organs from donors with positive SARS‐CoV‐2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee	6
Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023	6
Cell‐free next‐generation sequencing impacts diagnosis and antimicrobial therapy in immunocompromised hosts: A retrospective study	6
Evaluation of Crushed Posaconazole Delayed Release Tablets in Lung Transplant Recipients	6
Favorable outcomes of COVID‐19 in vaccinated hematopoietic stem cell transplant recipients: A single‐center experience	6
Can Quantitative Polymerase Chain Reaction in Tissue Improve Cytomegalovirus Management? Balancing Diagnostic Sensitivity and the Risk of Overtreatment	6
Impact of Pretransplant Antimicrobial Sulfonamide Allergy Label in Kidney Transplant Recipients	6
	6
Real‐World Data‐Based Exploration of Prophylactic Duration for a Specific Antibacterial Agent and Infection Incidence Post Kidney Transplantation	6
Implementation of a Protocol With a Shortened Vancomycin Prophylaxis Duration is Associated With Reduced Acute Kidney Injury in Lung Transplant Recipients: A Quasi‐Experimental Study	6
Infection evaluation in the early period after liver transplantation: A single‐center exploration	6
Primary Prophylaxis for Clostridioides difficile Infection in Lung Transplant Recipients: A Retrospective Study	6
Alternative Pneumocystis Pneumonia Prophylaxis in Solid Organ Transplants	6
Organ vigilance in the Middle East: Challenges and prospects	6
Twelve‐month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients	6
Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept	6
Myonecrosis: A Rare Presentation of Cytomegalovirus Disease	6
Post‐transplant lymphoproliferative disorder in pediatric liver transplant recipients: Experience from a South African transplant center	6
Road map to success: Advice for transplant infectious diseases job interviews, negotiation, and early career development	6
Detectable plasma severe acute respiratory syndrome coronavirus 2 spike antigen is associated with poor antibody response following third messenger RNA vaccination in kidney transplant recipients	6
Short‐course antibiotic treatment for Gram‐negative bloodstream infection in neutropenic cancer patients: Less is more	6
A randomized, placebo‐controlled, dose‐escalation phase I/II multicenter trial of low‐dose cidofovir for BK polyomavirus nephropathy	6
CMV prevention strategies in allogeneic hematopoietic cell transplantation; the role of prophylaxis and pre‐emptive monitoring in the era of letermovir	6

Nocardiosis in Immunocompromised Hosts: A Retrospective, Single‐Center Analysis of Clinical and Microbiological Determinants of Central Nervous System Involvement	6
Kidney Transplant Recipients Develop Nasal Mucosal Antibodies to SARS‐CoV‐2 With ACE2‐Inhibiting Activity Following mRNA Vaccination	6
Impact of COVID‐19 on abdominal organ transplantation: A bibliometric analysis	6
Social Media Savvy, It's More Than Just the #Hashtags: How the Use of Social Media in Transplant Infectious Diseases Can Impact the Field and Patients	6
	6
	5
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non‐renal solid organ transplant recipients?	5
Recurrent Outbreak of Carbapenem‐Resistant IMP‐1‐Producing Pseudomonas aeruginosa in Kidney Transplant Recipients: The Impact of Prolonged Patient Colonization	5
Biofire pneumonia panel in lung donors: faster detection but limited pathogens	5
Cefiderocol utilization in lung transplant recipients at a single center	5
Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual	5
Minding the gap: How transplant infectious disease can help close the organ donation gap	5
Infections in patients with primary immunodeficiencies: Insight into infections in secondary immunodeficiency and transplantation	5
	5
Expanding the Donor Pool: Transplantation of Hepatitis B and Hepatitis C Coinfected Kidneys	5
Daptomycin‐associated pulmonary toxicity sans eosinophilia in a hematopoietic cell transplant recipient with profound leukopenia	5
Effect of Antibiotics With Anaerobic Coverage on Graft‐Versus‐Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta‐Analysis	5
Antimicrobial stewardship for organ donors: Importance, current practice, and challenges	5
Re: Universal Multiplex Panel Testing of Donor Lungs as a Strategy to Optimize Antibiotic Prophylaxis against Multidrug‐Resistant Bacteria	5
Cytomegalovirus (CMV) Serostatus Reassessment in CMV Seronegative Kidney Transplant Candidates	5
Donor blood cultures and outcomes after lung transplantation: a single‐center report	5
Angioinvasive Hepatic Mucormycosis in a Heart Transplant Recipient	5
Pan‐European Fragile Populations Cohort for COVID‐19: What Worked, What Didn't, and Lessons Learned	5
Vaccine Adjuvants in the Immunocompromised Host: Science, Safety, and Efficacy	5
Impact of high MELD scores on CMV viremia following liver transplantation	5
Letermovir for pre‐emptive cytomegalovirus therapy after allogeneic hematopoietic cell transplantation	5
Longitudinal monitoring of BKPyV miRNA levels in kidney transplant recipients with BKPyV‐related pathology reflects viral DNA levels and remain high in viremia patients after clearance of viral DNA	5
Multidrug‐Resistant Gram‐Negative Urinary Tract Infections (UTIs) Increase the Risk of Rejection, CMV Viremia, and Graft Loss After Kidney Transplantation	5
Unravelling the Mystery: Abdominal Pain in a Solid Organ Transplant Recipient	5
Comparative analysis and trends in liver transplant hospitalizations with Clostridium difficile infections: A 10‐year national cross‐sectional study	5
Crusted Scabies with Facial Involvement in a Patient Following Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report	5
Cowdry A Bodies of Varicella Zoster Virus in a Renal Transplant Recipient	5
What Would You Choose? Oral CMV Prophylaxis in Maintenance Hemodialysis Patients After Solid Organ Transplantation	5
“They paged me what?”: A transplant infectious disease guide to donor calls	5
Uses of Human Tissue Bioburden Data	5
	4
Disseminated Nocardia yamashiensis , an Uncommon Subspecies	4
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis	4
Multifocal cutaneous Mycobacterium ulcerans infection in a heart transplant recipient	4
Hypercalcemia associated with Pneumocystis jirovecii pneumonia in lung transplant recipients: Two case reports	4
Pure Red Cell Aplasia and C3‐Dominant Glomerulonephritis Secondary to Parvovirus B19 in Post Kidney Transplantation Patient: A Case Report	4
Achieving Beta‐Lactam Goals During the Critical Collision of ARC in OLT Patients	4
The nuts and bolts of transplant infectious disease training	4
Critical Insights: Severe Outcomes of Pneumocystis Pneumonia: A 10‐year Retrospective Cohort Study	4
Hemorrhage Incognito	4
Antimicrobial stewardship in solid organ transplant—Opportunities in the National Health Service	4
Evolving trends in immunosuppression use and cytomegalovirus infection risk over the past decade in kidney transplantation	4
Issue Information	4
Development of a Kidney Transplant‐Specific DOOR for Urinary Tract Infections Assessing the Impact of Carbapenem Resistance	4
Evaluation of severe acute respiratory syndrome coronavirus 2 monoclonal antibodies in high‐risk solid organ transplant recipients across three major coronavirus disease 2019 variant waves	4
Cytomegalovirus Retinitis During Idecabtagene Vicleucel Therapy in Patients With Relapsed/Refractory Multiple Myeloma	4
Mpox in Solid Organ Transplant Recipients: Lessons from a Single‐Center Case Series in South Florida	4
Possible Donor‐Derived Tuberculosis in an Orthotopic Heart Transplant Recipient	4
Transplantation of organs from SARS‐CoV‐2‐positive donors: Preliminary experience from Spain	4
Infections after chimeric antigen receptor (CAR)‐T‐cell therapy for hematologic malignancies	4
Is diagnostic stewardship possible in solid organ transplantation?	4
Disseminated Blastomycosis Presenting With Skin Lesions in a Renal Transplant Recipient	4
Outcomes of SARS‐CoV‐2 infection among lung transplant recipients: A single center retrospective study	4
Clinical and healthcare burden of disease associated with cytomegalovirus in allogeneic hematopoietic stem cell transplantation – A retrospective single‐center study	4
Addressing the Rising Burden of Carbapenemase‐Producing Enterobacterales in Liver Transplant Recipients: A Call for Enhanced Surveillance and Prevention Strategies	4
Issue Information	4
	4
A Scoping Review of Arthropod‐Borne Flavivirus Infections in Solid Organ Transplant Recipients	4
	4
Issue Information	4
Sulfonamide allergy label and the risk of opportunistic infections in solid organ transplant recipients – A retrospective matched cohort study	4
When Colonization Is Not the Culprit: Multidrug‐Resistant Gram‐Negative Urinary Tract Infections as a Marker of Risk After Kidney Transplantation	4
Current management of SARS‐CoV‐2 infection in solid organ transplant recipients: Experience derived from an ESGICH–ESOT survey	4
Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances	4
Use of live viral vaccines after HCT: Still a lot to learn	4
Issue Information	4
Beta‐lactam allergies, surgical site infections, and prophylaxis in solid organ transplant recipients at a single center: A retrospective cohort study	4
Successful Combination Therapy with Cefiderocol and Sulbactam‐Durlobactam for Donor‐Derived Carbapenem‐Resistant Acinetobacter baumannii in a Kidney Tran	4
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria	4
Donor‐Derived Disseminated Amebiasis of Balamuthia mandrillaris After Kidney Transplant	4
Induction immunosuppression in kidney transplant recipients with HIV: To deplete or not to deplete?	4
Early clearance of BK polyomavirus‐DNAemia among kidney transplant recipients may lead to better graft survival	4
Combined assessment of Epstein–Barr virus viral capsid antigen and Epstein–Barr virus nuclear antigen‐1 serology for post‐transplant lymphoproliferative disorder risk stratification in adult solid org	4
The black urine challenge	4
Management of vancomycin‐resistant Enterococci and daptomycin‐resistant Enterococci infections in liver transplant recipients in a single academic center	4
Goals to score: The need for a minimum reporting dataset in studies of infection events in immunocompromised patients	4
Metronidazole‐induced encephalopathy after living donor liver transplantation	4
Transplant Infectious Disease Training: Bridging the Gap	4
The cascade of care in testing and treatment of latent tuberculosis infection in liver transplant candidates	4
Current state of antimicrobial stewardship and organ transplantation in Saudi Arabia	4
Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancy	4
Comparison of Rifampin and Isoniazid for Latent Tuberculosis Infection in Kidney Transplant Candidates: Focus on Tolerability and Treatment Completion	4
Investigation of donor‐derived Strongyloides stercoralis infection in multiple solid organ transplant recipients—California, Michigan, Ohio, 2022	4
Bridging the Gap Between General and Transplant Infectious Disease Practice	4
Changing the culture of blood cultures: Opportunities for diagnostic stewardship in febrile neutropenia	4